GAPDH and Alzheimer disease: In the specific case of neurodegeneration, a series of contributions aimed to determine the suitability of this gene demonstrated an abnormal aggregation of GAPDH protein product in the nucleus of cells from AD patients together with an increased activity of this enzyme in the diseased tissues, keeping in line with a direct and/or indirect correlation of GAPDH with the neurodegenerative process [9,10].